Ado-trastuzumab emtansine: prices and alternatives
Ado-trastuzumab emtansine (T-DM1) is a HER2-targeted antibody-drug conjugate indicated as a single agent for HER2-positive metastatic breast cancer in patients previously treated with trastuzumab and a taxane. It is also indicated for the adjuvant treatment of HER2-positive early breast cancer with residual invasive…
2 products with this active ingredient from 1 manufacturer. Official prices from 54440 to 86370 EGP.
Every box with this active ingredient, cheapest first.
Informational only — may be inaccurate or incomplete. Don't rely on it medically; verify with a pharmacist.

